| | | 49137 | | 15.08.1988 | | Novartis Pharma Schweiz AG | | 06.11.2007 | | | | | | | | | | | 07.16.20. | | | | 07.16.20. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Sandostatin 0,05 mg/mL | Injektionslösung | Solution injectable (Octreotide 0.05 mg) | H01CB02 | IPat | | 02 | Sandostatin 0,1 mg/mL | Injektionslösung | Solution injectable (Octreotide 0.1 mg) | H01CB02 | IPat | | 03 | Sandostatin 0,2 mg/mL | Injektionslösung | Solution injectable (Octreotide 0.2 mg) | H01CB02 | IPat | | 04 | Sandostatin 0,5 mg/mL | Injektionslösung | Solution injectable (Octreotide 0.5 mg) | H01CB02 | IPat |
|
|
